5h-furan-2-one derivatives stabilization of organic material

US2016362535A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016362535-A1
Application numberUS-201615248953-A
CountryUS
Kind codeA1
Filing dateAug 26, 2016
Priority dateMay 2, 2011
Publication dateDec 15, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A composition, which comprises a) an organic material susceptible to oxidative, thermal or light-induced degradation; and b) a compound of formula I (Formula I) (I) where R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are independently from each other H, C 1 -C 8 -alkyl, C 4 -C 8 -cycloalkyl, phenyl, C 1 -C 4 -alkoxy or halogen; n is 1, 2, 3, or 4; and when n is 1 A is —C(=0)-OR′ 1 , —C(=0)-N(R ′2 )(R′ 3 ), —CN, phenyl, which is unsubstituted or substituted by one or more C 1 -C 8 -alkyl, C 4 -C 8 -alkoxy, C 5 -C 7 -cycloalkyl or halogen, —H or —S0 2 -phenyl; when n is 2 A is —C(=0)-0-Z 1 —O—C(=0)-, —C(=0)-N(R″ 1 )—Z 2 —N(R″ 2 )—C(=0)- or piperazine-N,N′-biscarbonyl.

First claim

Opening claim text (preview).

1 . A composition, which comprises a) a polyolefin, a polyether polyol, or a polyurethane; and b) a compound of formula I wherein n is 1 or 2; when n is 1, A is —C(═O)—OR′ 1 , —C(═O)—N(R′ 2 )(R′ 3 ), —CN, phenyl which is unsubstituted or substituted by one or more C 1 -C 8 -alkyl, C 1 -C 4 -alkoxy, C 5 -C 7 -cycloalkyl or halogen, —H or —SO 2 -phenyl; and when n is 2, A is —C(═O)—O—Z 1 —O—C(═O)—, —C(═O)—N(R″ 1 )—Z 2 —N(R″ 2 )—C(═O)— or piperazine-N,N′-biscarbonyl; R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are independently from each other H, C 1 -C 8 -alkyl, C 4 -C 8 -cycloalkyl, phenyl, C 1 -C 4 -alkoxy or halogen; R′ 1 is H, C 1 -C 22 -alkyl, C 2 -C 18 -alkenyl, C 3 -C 12 -alkine-yl, C 4 -C 8 -cycloalkyl which is unsubstituted or substituted by one to three C 1 -C 4 -alkyl, C 4 -C 8 -cycloalkyl-C 1 -C 4 -alkyl bicyclic or tricyclic C 5 -C 20 -alkyl, C 6 -C 14 -aryl-C 1 -C 4 -alkyl, C 2 -C 12 -alkyl which is substituted by one or more hydroxyl groups, C 4 -C 12 -alkyl which is interrupted by one or more oxygen atoms, C 4 -C 18 -alkyl which is interrupted by one sulfur atom, 2,2,6,6-tetramethylpiperidine-4-yl, 1-(C 1 -C 8 -alkyl)-2,2,6,6-tetramethylpiperidine-4-yl or 1-(C 1 -C 8 -alkoxy)-2,2,6,6-tetramethylpiperidine-4-yl; R′ 2 and R′ 3 are independently from each other H, C 1 -C 22 -alkyl, C 2 -C 18 -alkenyl, C 4 -C 8 -cycloalkyl which is unsubstituted or substituted by one to three C 1 -C 4 -alkyl, C 6 -C 10 -aryl, C 4 -C 8 -cycloalkyl-C 1 -C 4 -alkyl, C 6 -C 14 -aryl-C 1 -C 4 -alkyl, C 2 -C 8 -alkyl which is substituted by one hydroxyl group, 2,2,6,6-tetramethylpiperidine-4-yl, 1-(C 1 -C 8 -alkyl)-2,2,6,6-tetramethylpiperidine-4-yl or 1-(C 1 -C 8 -alkoxy)-2,2,6,6-tetramethylpiperidine-4-yl, or R′ 2 and R′ 3 form together with the nitrogen atom to which they are attached a 5-, 6- or 7-membered saturated heterocycle; R″ 1 and R″ 2 are independently from each other H, C 1 -C 22 -alkyl, C 2 -C 18 -alkenyl, C 4 -C 8 -cycloalkyl which is unsubstituted or substituted by one to three C 1 -C 4 -alkyl, C 4 -C 8 -cycloalkyl-C -C 4 -alkyl or C 6 -C 14 -aryl-C 1 -C 4 -alkyl; Z 1 is C 2 -C 12 -alkylene, C 4 -C 8 -cycloalkylene, C 4 -C 8 -cycloalkane-bis-(C 1 -C 4 -alkylene), C 6 -C 14 -arene-bis-(C 1 -C 4 -alkylene), C 3 -C 6 -alkylene which is substituted by one or more hydroxyl groups, C 4 -C 12 -alkylene which is interrupted by one or more oxygen atoms, hexahydro-furo[3,2-b]furane-3,6-diyl, C 4 -C 8 -alkylene which is interrupted by a sulfur atom, 3-(C 1 -C 8 -alkyl)-3-azapentane-1,5-diyl, 4-(C 1 -C 8 -alkyl)-4-azaheptane-1,7-diyl or 1-ethyl-2,2,6,6-tetramethylpiperidine-4,2′-diyl; and Z 2 is C 2 -C 12 -alkylene, C 4 -C 8 -cycloalkylene, C 6 -C 14 -arylene, C 4 -C 8 -cycloalkane-bis(C 1 -C 4 -alkylene), C 6 -C 14 -arene-bis-(C 1 -C 4 -alkylene), C 4 -C 12 -alkylene which is interrupted by one or more oxygen atoms, 3-(C 1 -C 8 -alkyl)-3-azapentane-1,5-diyl or 4-(C 1 -C 8 -alkyl)-4-azaheptane-1,7-diyl. 2 . A composition according to claim 1 , where in the compound of formula I, n is 1 or 2 when n is 1, A is —C(═O)—OR′ 1 , —C(═O)—N(R′ 2 )(R′ 3 ), —CN, phenyl which is unsubstituted or substituted by one to three C 1 -C 8 -alkyl or C 1 -C 4 -alkoxy, —H or —SO 2 -phenyl; when n is 2, A is —C(═O)—O—Z 1 —O—C(═O)—, —C(═O)—N(R″ 1 )—Z 2 —N(R″ 2 )—C(═O)— or piperazine-N,N′-biscarbonyl; R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are independently from each other H, C 1 -C 8 -alkyl, phenyl or C 1 -C 4 -alkoxy with the proviso that at least R 1 or R 5 is H and at least R 6 or R 10 is H; R′ 1 is H, C 1 -C 22 -alkyl, C 2 -C 18 -alkenyl, C 5 -C 7 -cycloalkyl which is unsubstituted or substituted by one C 1 -C 4 -alkyl, C 5 -C 7 -cycloalkyl-C 1 -C 4 -alkyl, C 6 -C 10 -aryl-C 1 -C 4 -alkyl, C 4 -C 12 -alkyl which is interrupted by one or more oxygen atoms, 2,2,6,6-tetramethylpiperidine-4-yl, 1-(C 1 -C 6 -alkyl)-2,2,6,6-tetramethylpiperidine-4-yl or 1-(C 1 -C 6 -alkoxy)-2,2,6,6-tetramethylpiperidine-4-yl; R′ 2 and R′ 3 are independently from each other H, C 1 -C 22 -alkyl, C 2 -C 18 -alkenyl, C 5 -C 7 -cycloalkyl which is unsubstituted or substituted by one C 1 -C 4 -alkyl, C 6 -C 10 -aryl, C 5 -C 7 -cycloalkyl-C 1 -C 4 -alkyl, C 6 -C 10 -aryl-C 1 -C 4 -alkyl, 2,2,6,6-tetramethylpiperidine-4-yl, 1-(C 1 -C 6 -alkyl)-2,2,6,6-tetramethylpiperidine-4-yl or 1-(C 1 -C 6 -alkoxy)-2,2,6,6-tetramethylpiperidine-4-yl, or R′ 2 and R′ 3 form together with the nitrogen atom to which they are attached a pyrrolidine, a piperidine or a morpholine; R″ 1 and R″ 2 independently from each other H, C 1 -C 22 -alkyl, C 2 -C 18 -alkenyl, C 5 -C 7 -cycloalkyl which is unsubstituted or substituted by one C 1 -C 4 -alkyl, C 5 -C 7 -cycloalkyl-C 1 -C 4 -alkyl or C 6 -C 10 -aryl-C 1 -C 4 -alkyl; Z 1 is C 2 -C 12 -alkylene, C 5 -C 7 -cycloalkylene, C 5 -C 7 -cycloalkane-bis-(C 1 -C 4 -alkylene), C 6 -C 10 -arene-bis-(C 1 -C 4 -alkylene), C 3 -C 6 -alkylene which is substituted by one or more hydroxyl groups, C 4 -C 12 -alkylene which is interrupted by one or more oxygen atoms, C 4 -C 8 -alkylene which is interrupted by a sulfur atom, 3-(C 1 -C 4 -alkyl)-3-azapentane-1,5-diyl, 4-(C 1 -C 4 -alkyl)-4-azaheptane-1,7-diyl or 1-ethyl-2,2,6,6-tetramethylpiperidine-4,2′-diyl; and Z 2 is C 2 -C 12 -alkylene, C 5 -C 7 -cycloalkylene, C 6 -C 14 -arylene, C 5 -C 7 -cycloalkane-bis(C 1 -C 4 -alkylene), C 6 -C 10 -arene-bis-(C 1 -C 4 -alkylene), C 4 -C 12 -alkylene which is interrupted by one or more oxygen atoms, 3-(C 1 -C 4 -alkyl)-3-azapentane-1,5-diyl or 4-(C 1 -C 4 -alkyl)-4-azaheptane-1,7-diyl. 3 . A composition according to claim 1 , where in the compound of formula I, n is 1 or 2; when n is 1, A is —C(═O)—OR′ 1 , —C(═O)—N(R′ 2 )(R′ 3 ), —CN, phenyl, —H or —SO 2 -phenyl; when n is 2, A is —C(═O)—O—Z 1 —O—C(═O)—; n is 1 or 2; R 1 , R 2 , R 4 , R 5 , R 6 , R 7 , R 9 and R 10 are H; R 3 and R 8 are independently from each other H or C 1 -C 4 -alkoxy; R′ 1 is H, C 1 -C 12 -alkyl, C 5 -C 7 -cycloalkyl which is unsubstituted, phenyl-C 1 -C 4 -alkyl, 1-(C 1 -C 6 -alkyl)-2,2,6,6-tetramethylpiperidine-4-yl or 1-(C 1 -C 6 -alkoxy)-2,2,6,6-tetramethylpiperidine-4-yl; R′ 2 and R′ 3 are independently from each other H, C 1 -C 12 -alkyl, C 5 -C 7 -cycloalkyl which is unsubstituted, C 6 -C 10 -aryl, phenyl-C 1 -C 4 -alkyl, 1-(C 1 -C 6 -alkyl)-2,2,6,6-tetramethylpiperidine-4-yl or 1-(C 1 -C 6 -alkoxy)-2,2,6,6-tetramethylpiperidine-4-yl, or R′ 2 and R′ 3 form together with the nitrogen atom to which they are attached a pyrrolidine, a piperidine or a morpholine; and Z 1 is C 5 -C 7 -cycloalkylene. 4 .- 6 . (canceled) 7 . A composition according to claim 1 , wherein component b) is contained in an amount of 0.005% to 10% based on the weight of component a). 8 . A composition according to claim 1 , c) a further additive. 9 . A composition according to claim 8 , which comprises c) an additive selected from the group consisting of a phosphite, a phosphonite, an acid scavenger, a phenolic antioxidant, and an aminic antioxidant. 10 . A composition according to claim 8 , wherein the weight ratio of b) to c) is from 4:1 to 1:20. 11 . A composition according to claim 9 , which comprises d) a second further additive selected from the group consisting of a phosphite, a phosphonite, an acid scavenger, a phenolic antioxidant and an aminic antioxidant. 12 . A process for protection of a polyolefin, a polyether polyol, or a polyurethane susceptible to oxidative, thermal or light-induced degradation, w

Assignees

Inventors

Classifications

  • containing sulfur and oxygen · CPC title

  • containing nitrogen and oxygen · CPC title

  • C08K5/1535Primary

    Five-membered rings · CPC title

  • Phenols; Phenolates · CPC title

  • with hydroxyaryl compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016362535A1 cover?
A composition, which comprises a) an organic material susceptible to oxidative, thermal or light-induced degradation; and b) a compound of formula I (Formula I) (I) where R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are independently from each other H, C 1 -C 8 -alkyl, C 4 -C 8 -cycloalkyl, phenyl, C 1 -C 4 -alkoxy or halogen; n is 1, 2, 3, or 4; and when n is 1 A is —C(=0)-OR…
Who is the assignee on this patent?
Basf Se
What technology area does this patent fall under?
Primary CPC classification C08K5/1535. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Dec 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).